Moderna
MRNA
#299
Rank
$78.97 B
Marketcap
$197.81
Share price
2.72%
Change (1 day)
665.81%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of October 2026 (TTM): -137.78%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -137.78%. At the end of 2025 the company had an Operating Margin of -144.02%.

Operating Margin history for Moderna from 2018 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-144.02%27.73%
2024-112.75%93.19%
2023-58.37%-215.05%
202250.73%-32.28%
202174.90%-127.59%
2020-271.53%-74.69%
2019-1,072.92%241.94%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-125.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
27.37%-119.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
32.40%-123.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-118.00%-14.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-55.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,576.98% 1,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
8.70%-106.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
6.21%-104.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.